1. Incomplete myelopathy and human T cell lymphotropic virus type-1 (HTLV-1)

   • Roberta Vilela Lopes Koyama
   • Gilberto Toshimitsu Yoshikawa
   • Hellen Thaís Fuzii

   OriginalPaper 05 October 2018 Pages: 1 - 8

   

2. Effects of age, HIV, and HIV-associated clinical factors on neuropsychological functioning and brain regional volume in HIV+ patients on effective treatment

   • Natalia Gawron
   • M. Choiński
   • E. Łojek

   OriginalPaper Open access 08 October 2018 Pages: 9 - 21

   

3. Similar neurocognitive outcomes after 48 weeks in HIV-1-infected participants randomized to continue tenofovir/emtricitabine + atazanavir/ritonavir or simplify to abacavir/lamivudine + atazanavir

   • Kevin Robertson
   • Paul Maruff
   • Mark S. Shaefer

   OriginalPaper Open access 08 October 2018 Pages: 22 - 31

4. White matter damage, neuroinflammation, and neuronal integrity in HAND

   • Aljoharah Alakkas
   • Ronald J. Ellis
   • for the CHARTER Group

   OriginalPaper Open access 05 October 2018 Pages: 32 - 41

   

5. The bovine herpesvirus 1 regulatory proteins, bICP4 and bICP22, are expressed during the escape from latency

   • Junqing Guo
   • Qingmei Li
   • Clinton Jones

   OriginalPaper 06 November 2018 Pages: 42 - 49

   

6. Multimodal techniques failed to detect cytomegalovirus in human glioblastoma samples

   • Marie-Pierre Loit
   • Homa Adle-Biassette
   • Jean-Michel Molina

   OriginalPaper 05 November 2018 Pages: 50 - 56

   

7. Enhanced facilitation and diminished inhibition characterizes the pronociceptive endogenous pain modulatory balance of persons living with HIV and chronic pain

   • Michael A. Owens
   • Romy Parker
   • Burel R. Goodin

   OriginalPaper 09 November 2018 Pages: 57 - 71

   

8. Empiric neurocognitive performance profile discovery and interpretation in HIV infection

   • Daniela Gomez
   • Christopher Power
   • Esther Fujiwara

   OriginalPaper 05 December 2018 Pages: 72 - 84

   

9. Tryptophan metabolism and its relationship with central nervous system toxicity in people living with HIV switching from efavirenz to dolutegravir

   • Michael R. Keegan
   • Alan Winston
   • Mark Nelson

   OriginalPaper Open access 26 November 2018 Pages: 85 - 90

10. Herpes zoster increased risk of neuralgic amyotrophy: a retrospective, population-based matched cohort study

    • Tsung-Yen Ho
    • Chi-Hsiang Chung
    • Yung-Tsan Wu

    OriginalPaper 05 November 2018 Pages: 91 - 100

    

11. HERV-W env regulates calcium influx via activating TRPC3 channel together with depressing DISC1 in human neuroblastoma cells

    • Yatang Chen
    • Qiujin Yan
    • Fan Zhu

    OriginalPaper 05 November 2018 Pages: 101 - 113

    

12. HIV-1 infection renders brain vascular pericytes susceptible to the extracellular glutamate

    • Dorota Piekna-Przybylska
    • Kavyasri Nagumotu
    • Sanjay B. Maggirwar

    OriginalPaper 06 November 2018 Pages: 114 - 126

    

13. Vibrio vulnificus meningoencephalitis in a patient with thalassemia and a splenectomy

    • Rongni He
    • Wenxia Zheng
    • Huifang Xie

    Case Report 05 November 2018 Pages: 127 - 132

    

14. Quantitative electroencephalography supports diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy

    • G. Classen
    • C. Classen
    • R. Hoepner

    Case Report 09 November 2018 Pages: 133 - 136

    

15. Recurrent strokes, central nervous system vasculitis, and acquired protein S deficiency secondary to varicella zoster in a child with AIDS

    • Jake A. Deviley
    • Darby Oldenburg
    • William A. Agger

    Case Report 26 November 2018 Pages: 137 - 140